The global intrauterine contraceptive devices market is expected to grow at a CAGR of 3.5% during the forecast period, to reach USD 2.2 billion by 2030. The growth of this market is driven by the increasing awareness about contraception and rising demand for long-term contraception methods among women in developing countries. Hormonal IUCDs are expected to dominate the global intrauterine contraceptive devices market during the forecast period, accounting for over 50% share of total revenue in 2018. Hormonal IUCDs are preferred due to their effectiveness and convenience as they can be inserted into uterus without surgery or anesthesia and can be left inside for up to 10 years without any need for removal or replacement. Copper IUCDs are also gaining popularity due to their low cost and ease of use as they do not require any insertion procedure or removal after a certain duration like hormonal IUCDs do.
- The IUD market is expected to reach $2,890 million by 2022.
- Increasing awareness about the benefits of IUDs and increasing number of women in the reproductive age group are some factors that are driving the growth of this market.
- Increasing use of long-acting reversible contraceptives (LARC) such as intrauterine devices (IUDs) and implants for birth control purposes is also driving the growth of this market.
- Lack of awareness about side effects associated with intrauterine devices and lack of skilled healthcare professionals in developing countries are some factors that may hamper the growth rate.
Industry Growth Insights published a new data on “Intrauterine Contraceptive Devices Market”. The research report is titled “Intrauterine Contraceptive Devices Market research by Types (Hormonal IUCD, Copper IUCD), By Applications (Hospitals, Gynecological Clinics, Other), By Players/Companies Teva Pharmaceutical Industries, Medicines360, Trimedic Supply Network Ltd., Bayer Healthcare Ag (Subsidiary of Bayer Ag), Actavis PLC, Medisafe Distribution Inc., Pace Pharmaceuticals”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Intrauterine Contraceptive Devices Market Research Report
By Type
Hormonal IUCD, Copper IUCD
By Application
Hospitals, Gynecological Clinics, Other
By Companies
Teva Pharmaceutical Industries, Medicines360, Trimedic Supply Network Ltd., Bayer Healthcare Ag (Subsidiary of Bayer Ag), Actavis PLC, Medisafe Distribution Inc., Pace Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Intrauterine Contraceptive Devices Market Report Segments:
The global Intrauterine Contraceptive Devices market is segmented on the basis of:
Types
Hormonal IUCD, Copper IUCD
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Gynecological Clinics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Teva Pharmaceutical Industries
- Medicines360
- Trimedic Supply Network Ltd.
- Bayer Healthcare Ag (Subsidiary of Bayer Ag)
- Actavis PLC
- Medisafe Distribution Inc.
- Pace Pharmaceuticals
Highlights of The Intrauterine Contraceptive Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hormonal IUCD
- Copper IUCD
- By Application:
- Hospitals
- Gynecological Clinics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Intrauterine Contraceptive Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Intrauterine contraceptive devices (IUDs) are a type of birth control that are inserted into the uterus by a doctor. IUDs work by preventing sperm from fertilizing an egg. IUDs can be used for up to 10 years and may also help prevent pelvic inflammatory disease (PID).
Some of the major companies in the intrauterine contraceptive devices market are Teva Pharmaceutical Industries, Medicines360, Trimedic Supply Network Ltd., Bayer Healthcare Ag (Subsidiary of Bayer Ag), Actavis PLC, Medisafe Distribution Inc., Pace Pharmaceuticals.
The intrauterine contraceptive devices market is expected to register a CAGR of 3.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Intrauterine Contraceptive Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Intrauterine Contraceptive Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Intrauterine Contraceptive Devices Market - Supply Chain
4.5. Global Intrauterine Contraceptive Devices Market Forecast
4.5.1. Intrauterine Contraceptive Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Intrauterine Contraceptive Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Intrauterine Contraceptive Devices Market Absolute $ Opportunity
5. Global Intrauterine Contraceptive Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Intrauterine Contraceptive Devices Market Size and Volume Forecast by Type
5.3.1. Hormonal IUCD
5.3.2. Copper IUCD
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Intrauterine Contraceptive Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Intrauterine Contraceptive Devices Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Gynecological Clinics
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Intrauterine Contraceptive Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Intrauterine Contraceptive Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Intrauterine Contraceptive Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Intrauterine Contraceptive Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Intrauterine Contraceptive Devices Demand Share Forecast, 2019-2026
9. North America Intrauterine Contraceptive Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Intrauterine Contraceptive Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Intrauterine Contraceptive Devices Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Gynecological Clinics
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Intrauterine Contraceptive Devices Market Size and Volume Forecast by Type
9.7.1. Hormonal IUCD
9.7.2. Copper IUCD
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Intrauterine Contraceptive Devices Demand Share Forecast, 2019-2026
10. Latin America Intrauterine Contraceptive Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Intrauterine Contraceptive Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Intrauterine Contraceptive Devices Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Gynecological Clinics
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Intrauterine Contraceptive Devices Market Size and Volume Forecast by Type
10.7.1. Hormonal IUCD
10.7.2. Copper IUCD
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Intrauterine Contraceptive Devices Demand Share Forecast, 2019-2026
11. Europe Intrauterine Contraceptive Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Intrauterine Contraceptive Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Intrauterine Contraceptive Devices Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Gynecological Clinics
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Intrauterine Contraceptive Devices Market Size and Volume Forecast by Type
11.7.1. Hormonal IUCD
11.7.2. Copper IUCD
11.8. Basis Point Share (BPS) nalysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Intrauterine Contraceptive Devices Demand Share, 2019-2026
12. Asia Pacific Intrauterine Contraceptive Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Intrauterine Contraceptive Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Intrauterine Contraceptive Devices Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Gynecological Clinics
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Intrauterine Contraceptive Devices Market Size and Volume Forecast by Type
12.7.1. Hormonal IUCD
12.7.2. Copper IUCD
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Intrauterine Contraceptive Devices Demand Share, 2019-2026
13. Middle East & Africa Intrauterine Contraceptive Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Intrauterine Contraceptive Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Intrauterine Contraceptive Devices Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Gynecological Clinics
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Intrauterine Contraceptive Devices Market Size and Volume Forecast by Type
13.7.1. Hormonal IUCD
13.7.2. Copper IUCD
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Intrauterine Contraceptive Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Intrauterine Contraceptive Devices Market: Market Share Analysis
14.2. Intrauterine Contraceptive Devices Distributors and Customers
14.3. Intrauterine Contraceptive Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Teva Pharmaceutical Industries
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Medicines360
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Trimedic Supply Network Ltd.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bayer Healthcare Ag (Subsidiary of Bayer Ag)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Actavis PLC
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Medisafe Distribution Inc.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Pace Pharmaceuticals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook